[1]
|
Li, Y.L., Xiao, N.Q. and Tan, Z.J. (2020) Intestinal Microflora in Metabolic Diseases. World Chinese Journal of Digestology, 28, 1192-1199. https://doi.org/10.11569/wcjd.v28.i23.1192
|
[2]
|
Jia, X., Xu, W., Zhang, L., Li, X., Wang, R. and Wu, S.I. (2021) Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 634780. https://doi.org/10.3389/fcimb.2021.634780
|
[3]
|
Moon, J., Yoon, C.H., Choi, S.H. and Kim, M.K. (2020) Can Gut Microbiota Affect Dry Eye Syndrome? International Journal of Molecular Sciences, 21, Article No. 8443. https://doi.org/10.3390/ijms21228443
|
[4]
|
Li, C.X., Liu, H.Y., Lin, Y.X., et al. (2020) The Gut Microbiota and Respiratory Diseases: New Evidence. Journal of Immunology Research, 2020, Article ID: 2340670. https://doi.org/10.1155/2020/2340670
|
[5]
|
Anselmi, G., Gagliardi, L., Egidi, G., et al. (2021) Gut Microbiota and Cardiovascular Diseases: A Critical Review. Cardiology in Review, 29, 195-204. https://doi.org/10.1097/CRD.0000000000000327
|
[6]
|
Giuffrè, M., Campigotto, M., Campisciano, G., et al. (2020) A Story of Liver and Gut Microbes: How does the Intestinal Flora Affect Liver Disease? A Review of the Literature. The American Journal of Physiology-Gastrointestinal and Liver Physiology, 318, 889-906. https://doi.org/10.1152/ajpgi.00161.2019
|
[7]
|
Pluznick, J.L. (2020) The Gut Microbiota in Kidney Disease. Science, 369, 1426-1427. https://doi.org/10.1126/science.abd8344
|
[8]
|
Chambers, L.M., Bussies, P., Vargas, R., et al. (2021) The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities. Current Oncology Reports, 23, Article No. 92. https://doi.org/10.1007/s11912-021-01079-x
|
[9]
|
Li, R., Li, Y.F., Li, C., et al. (2020) Gut Microbiota and Endocrine Disorder. Advances in Experimental Medicine and Biology, 1238, 143-164. https://doi.org/10.1007/978-981-15-2385-4_9
|
[10]
|
Brim, H., Taylor, J., Abbas, M., et al. (2021) The Gut Microbiome in Sickle Cell Disease: Characterization and Potential Implications. PLOS ONE, 16, e0255956. https://doi.org/10.1371/journal.pone.0255956
|
[11]
|
Li, R., Boer, C.G., Oei, L., et al. (2021) The Gut Microbiome: A New Frontier in Musculoskeletal Research. Current Osteoporosis Reports, 19, 347-357. https://doi.org/10.1007/s11914-021-00675-x
|
[12]
|
Vangoitsenhoven, R. and Cresci, G.A.M. (2020) Role of Microbiome and Antibiotics in Autoimmune Diseases. Nutrition in Clinical Practice, 35, 406-416. https://doi.org/10.1002/ncp.10489
|
[13]
|
Zhu, S.B., Jiang, Y.F., Xu, K.L., et al. (2020) The Progress of Gut Microbiome Research Related to Brain Disorders. Journal of Neuroinflammation, 17, 1-20. https://doi.org/10.1186/s12974-020-1705-z
|
[14]
|
Wu, J., Wang, K., Wang, X., et al. (2021) The Role of the Gut Microbiome and Its Metabolites in Metabolic Diseases. Protein & Cell, 12, 360-373. https://doi.org/10.1007/s13238-020-00814-7
|
[15]
|
Rizvi, A.A., Stoian, A.P. and Rizzo, M. (2021) Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies. International Journal of Molecular Sciences, 22, Article No. 10038. https://doi.org/10.3390/ijms221810038
|
[16]
|
Karlsson, F.H., Tremaroli, V., Nookaew, I., et al. (2013) Gut Metagenome in European Women with Normal, Impaired and Diabetic Glucose Control. Nature, 498, 99-103. https://doi.org/10.1038/nature12198
|
[17]
|
Kc, D., Sumner, R. and Lippmann, S. (2020) Gut Microbiota and Health. Postgraduate Medicine, 132, Article No. 274. https://doi.org/10.1080/00325481.2019.1662711
|
[18]
|
Biedermann, L. and Rogler, G. (2015) The Intestinal Microbiota: Its Role in Health and Disease. European Journal of Pediatrics, 174, 151-167. https://doi.org/10.1007/s00431-014-2476-2
|
[19]
|
Zhao, Q. and Elson, C.O. (2018) Adaptive Immune Education by Gut Microbiota Antigens. Immunology, 154, 28-37. https://doi.org/10.1111/imm.12896
|
[20]
|
Farré, R., Fiorani, M., Abdu Rahiman, S., et al. (2020) Intestinal Permeability, Inflammation and the Role of Nutrients. Nutrients, 12, 11855-1203. https://doi.org/10.3390/nu12041185
|
[21]
|
Walrath, T., Dyamenahalli, K.U., Hulsebus, H.J., et al. (2020) Age-Related Changes in Intestinal Immunity and the Microbiome. Journal of Leukocyte Biology, 109, 1045-1061. https://doi.org/10.1002/JLB.3RI0620-405RR
|
[22]
|
Liébana-García, R., Olivares, M., Bullich-Vilarrubias, C., et al. (2021) The Gut Microbiota as a Versatile Immunomodulator in Obesity and Associated Metabolic Disorders. Best Practice & Research Clinical Endocrinology & Metabolism, 35, Article ID: 101542. https://doi.org/10.1016/j.beem.2021.101542
|
[23]
|
Zheng, D., Liwinski, T. and Elinav, E. (2020) Interaction between Microbiota and Immunity in Health and Disease. Cell Research, 30, 492-506. https://doi.org/10.1038/s41422-020-0332-7
|
[24]
|
Qin, J., Li, Y., Cai, Z., et al. (2012) A Metagenome-Wide Association Study of Gut Microbiota in Type 2 Diabetes. Nature, 490, 55-60. https://doi.org/10.1038/nature11450
|
[25]
|
Frost, F., Kacprowski, T., Rühlemann, M., et al. (2021) Long-Term Instability of the Intestinal Microbiome Is Associated with Metabolic Liver Disease, Low Microbiota Diversity, Diabetes Mellitus and Impaired Exocrine Pancreatic Function. Gut, 70, 522-530. https://doi.org/10.1136/gutjnl-2020-322753
|
[26]
|
Li, H.Y., Zhou, D.D., Gan, R.Y., et al. (2021) Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13, Article No. 3211. https://doi.org/10.3390/nu13093211
|
[27]
|
Zhang, M., Sun, K., Wu, Y., et al. (2017) Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Frontiers in Immunology, 8, Article No. 942. https://doi.org/10.3389/fimmu.2017.00942
|
[28]
|
Shoelson, S.E., Lee, J. and Goldfine, A.B. (2006) Inflammation and Insulin Resistance. Journal of Clinical Investigation, 116, 1793-1801. https://doi.org/10.1172/JCI29069
|
[29]
|
Ryu, J.K., Kim, S.J., Rah, S.H., et al. (2017) Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer. Immunity, 46, 38-50. https://doi.org/10.1016/j.immuni.2016.11.007
|
[30]
|
Richards, E.M., Li, J., Stevens, B.R., et al. (2022) Gut Microbiome and Neuroinflammation in Hypertension. Circulation Research, 130, 401-417. https://doi.org/10.1161/CIRCRESAHA.121.319816
|
[31]
|
Wang, Y. and Kasper, L.H. (2014) The Role of Microbiome in Central Nervous System Disorders. Brain, Behavior, and Immunity, 38, 1-12. https://doi.org/10.1016/j.bbi.2013.12.015
|
[32]
|
Gupta, A., Osadchiy, V. and Mayer, E.A. (2020) Brain-Gut-Microbiome Interactions in Obesity and Food Addiction. Nature Reviews Gastroenterology & Hepatology, 17, 655-672. https://doi.org/10.1038/s41575-020-0341-5
|
[33]
|
Dalile, B., Van Oudenhove, L., Vervliet, B., et al. (2019) The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Communication. Nature Reviews Gastroenterology & Hepatology, 16, 461-478. https://doi.org/10.1038/s41575-019-0157-3
|
[34]
|
Romaní-Pérez, M., Bullich-Vilarrubias, C., López-Almela, I., et al. (2021) The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis. International Journal of Molecular Sciences, 22, Article No. 5830. https://doi.org/10.3390/ijms22115830
|
[35]
|
Sommer, F., Nookaew, I., Sommer, N., et al. (2015) Site-Specific Programming of the Host Epithelial Transcriptome by the Gut Microbiota. Genome Biology, 16, Article No. 62. https://doi.org/10.1186/s13059-015-0614-4
|
[36]
|
Org, E., Mehrabian, M. and Lusis, A.J. (2015) Unravelig the Environmental and Genetic Interactions in Atherosclerosis: Central Role of the Gut Microbiota. Atherosclerosis, 241, 387-399. https://doi.org/10.1016/j.atherosclerosis.2015.05.035
|
[37]
|
Lee, Y.S. and Olefsky, J. (2021) Chronic Tissue Inflammation and Metabolic Disease. Genes & Development, 35, 307-328. https://doi.org/10.1101/gad.346312.120
|
[38]
|
Kimura, I., Inoue, D., Maeda, T., et al. (2011) Short-Chain Fatty Acids and Ketones Directly Regulate Sympathetic Nervous System via G Protein-Coupled Receptor 41 (GPR41). Proceedings of the National Academy of Sciences of the United States of America, 108, 8030-8035. https://doi.org/10.1073/pnas.1016088108
|
[39]
|
WHO (2021) Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
|
[40]
|
Liu, B.N., Liu, X.T., Liang, Z.H., et al. (2021) Gut Microbiota in Obesity. World Journal of Gastroenterology, 27, 3837-3850. https://doi.org/10.3748/wjg.v27.i25.3837
|
[41]
|
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., et al. (2006) An Obesity-Associated Gut Microbiome with Increased Capacity for Energy Harvest. Nature, 444, 1027-1031. https://doi.org/10.1038/nature05414
|
[42]
|
Martinez, K.B., Leone, V. and Chang, E.B. (2017) Western Diets, Gut Dysbiosis, and Metabolic Diseases: Are They Linked. Gut Microbes, 8, 130-142. https://doi.org/10.1080/19490976.2016.1270811
|
[43]
|
Duan, M., Wang, Y., Zhang, Q., Zou, R., et al. (2021) Characteristics of Gut Microbiota in People with Obesity. PLOS ONE, 16, e0255446. https://doi.org/10.1371/journal.pone.0255446
|
[44]
|
Alvarez-Arrano, V. and Martín-Peláez, S. (2021) Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients, 13, Article No. 3627. https://doi.org/10.3390/nu13103627
|
[45]
|
Kolb, H. and Martin, S. (2017) Environmental/Lifestyle Factors in the Pathogenesis and Prevention of Type 2 Diabetes. BMC Medicine, 15, Article No. 131. https://doi.org/10.1186/s12916-017-0901-x
|
[46]
|
Kitten, A.K., Ryan, L., Lee, G.C., et al. (2021) Gut Microbiome Differences among Mexican Americans with and without Type 2 Diabetes Mellitus. PLOS ONE, 16, e0251245. https://doi.org/10.1371/journal.pone.0251245
|
[47]
|
Barnett, R. (2017) Hypertension. The Lancet, 389, 2365. https://doi.org/10.1016/S0140-6736(17)31570-2
|
[48]
|
Zhang, G.X., Jin, L., Jin, H. and Zheng, G.S. (2021) Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota. Evidence-Based Complementary and Alternative Medicine, 2021, Article ID: 5563073. https://doi.org/10.1155/2021/5563073
|
[49]
|
Marx, J. (2001) Hypertension—Possible New Path for Blood Pressure Control. Science, 293, Article No. 1030. https://doi.org/10.1126/science.293.5532.1030a
|
[50]
|
Avery, E.G., Bartolomaeus, H., Maifeld, A., et al. (2021) The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives. Circulation Research, 128, 934-950. https://doi.org/10.1161/CIRCRESAHA.121.318065
|
[51]
|
Yang, T., Santisteban, M.M., Rodriguez, V., et al. (2015) Gut Dysbiosis Is Linked to Hypertension. Hypertension, 65, 1331-1340. https://doi.org/10.1161/HYPERTENSIONAHA.115.05315
|
[52]
|
Li, J., Zhao, F., Wang, Y., Chen, J., et al. (2017) Gut Microbiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14. https://doi.org/10.1186/s40168-016-0222-x
|
[53]
|
Louca, P., Nogal, A., Wells, P.M., et al. (2021) Gut Microbiome Diversity and Composition Is Associated with Hypertension in Women. Journal of Hypertension, 39, 1810-1816. https://doi.org/10.1097/HJH.0000000000002878
|
[54]
|
Deng, X., Ma, J., Song, M., et al. (2019) Effects of Products Designed to Modulate the Gut Microbiota on Hyperlipidaemia. European Journal of Nutrition, 58, 2713-2729. https://doi.org/10.1007/s00394-018-1821-z
|
[55]
|
Husain, M.J., Spencer, G., Nugent, R., et al. (2022) The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review. Global Heart, 17, Article No. 18. https://doi.org/10.5334/gh.1097
|
[56]
|
Aguilar-Salinas, C.A., Diaz-Polanco, A. and Quintana, E. (2002) Genetic Factors Play an Important Role in the Pathogenesis of Hyperlipidemia Post-Transplantation. American Journal of Kidney Diseases, 40, 169-177. https://doi.org/10.1053/ajkd.2002.33926
|
[57]
|
Wang, L., Li, C., Huang, Q. and Fu, X. (2020) Polysaccharide from Rosa roxburghii Tratt Fruit Attenuates Hyperglycemia and Hyperlipidemia and Regulates Colon Microbiota in Diabetic db/db Mice. Journal of Agricultural and Food Chemistry, 68, 147-159. https://doi.org/10.1021/acs.jafc.9b06247
|
[58]
|
Gargari, G., Deon, V., Taverniti, V., et al. (2018) Evidence of Dysbiosis in the Intestinal Microbial Ecosystem of Children and Adolescents with Primary Hyperlipidemia and the Potential Role of Regular Hazelnut Intake. FEMS Microbiology Ecology, 94, Article No. 5. https://doi.org/10.1093/femsec/fiy045
|
[59]
|
Moreno-Indias, I., Sanchez-Alcoholado, L., Perez-Martinez, P., et al. (2016) Red Wine Polyphenols Modulate Fecal Microbiota and Reduce Markers of the Metabolic Syndrome in Obese Patients. Food & Function, 7, 1775-1787. https://doi.org/10.1039/C5FO00886G
|
[60]
|
Tian, X., Wang, A., Wu, S., et al. (2021) Cumulative Serum Uric Acid and Its Time Course Are Associated with Risk of Myocardial Infarction and All-Cause Mortality. Journal of the American Heart Association, 10, e020180. https://doi.org/10.1161/JAHA.120.020180
|
[61]
|
Koto, R., Nakajima, A., Horiuchi, H., et al. (2021) Serum Uric Acid Control for Prevention of Gout Flare in Patients with Asymptomatic Hyperuricaemia: A Retrospective Cohort Study of Health Insurance Claims and Medical Check-Up Data in Japan. Annals of the Rheumatic Diseases, 80, 1483-1490. https://doi.org/10.1136/annrheumdis-2021-220439
|
[62]
|
Yin, H., Liu, N. and Chen, J. (2022) The Role of the Intestine in the Development of Hyperuricemia. Frontiers in Immunology, 13, Article ID: 845684. https://doi.org/10.3389/fimmu.2022.845684
|
[63]
|
Wang, J., Chen, Y., Zhong, H., et al. (2021) The Gut Microbiota as a Target to Control Hyperuricemia Pathogenesis: Potential Mechanisms and Therapeutic Strategies. Critical Reviews in Food Science and Nutrition, 62, 3979-3989. https://doi.org/10.1080/10408398.2021.1874287
|
[64]
|
Yang, H.T., Xiu, W.J., Liu, J.K., et al. (2021) Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: Probiotics Increased. Bioengineered, 12, 7263-7275. https://doi.org/10.1080/21655979.2021.1976897
|
[65]
|
Chen, K., Ma, J., Jia, X., et al. (2019) Advancing the Understanding of NAFLD to Hepatocellular Carcinoma Development: From Experimental Models to Humans. Biochimica et Biophysica Acta—Reviews on Cancer, 1871, 117-125. https://doi.org/10.1016/j.bbcan.2018.11.005
|
[66]
|
Younossi, Z., Tacke, F., Arrese, M., et al. (2019) Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology, 69, 2672-2682. https://doi.org/10.1002/hep.30251
|
[67]
|
Tilg, H., Moschen, A.R. and Roden, M. (2017) NAFLD and Diabetes Mellitus. Nature Reviews Gastroenterology & Hepatology, 14, 32-42. https://doi.org/10.1038/nrgastro.2016.147
|
[68]
|
Kaya, E. and Yilmaz, Y. (2022) Metabolic-Associated Fatty Liver Disease (MAFLD): A Multi-Systemic Disease beyond the Liver. Journal of Clinical and Translational Hepatology, 10, 329-338. https://doi.org/10.14218/JCTH.2021.00178
|
[69]
|
De Minicis, S., Rychlicki, C., Agostinelli, L., et al. (2014) Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice. Hepatology, 59, 1738-1749. https://doi.org/10.1002/hep.26695
|
[70]
|
Lee, N.Y., Joung, H.C., Kim, B.K., et al. (2020) Lactobacillus lactis CKDB001 Ameliorate Progression of Nonalcoholic Fatty Liver Disease through of Gut Microbiome: Addendum. Gut Microbes, 12, Article ID: 1829449. https://doi.org/10.1080/19490976.2020.1829449
|
[71]
|
Hoyles, L., Fernández-Real, J.M., Federici, M., et al. (2018) Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women. Nature Medicine, 24, 1070-1080. https://doi.org/10.1038/s41591-018-0061-3
|
[72]
|
Wang, B., Jiang, X., Cao, M., et al. (2016) Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-Alcoholic Fatty Liver Disease. Scientific Reports, 6, Article No. 32002. https://doi.org/10.1038/srep32002
|
[73]
|
Michail, S., Lin, M., Frey, M.R., et al. (2015) Altered Gut Microbial Energy and Metabolism in Children with Non-Alcoholic Fatty Liver Disease. FEMS Microbiology Ecology, 91, 1-9. https://doi.org/10.1093/femsec/fiu002
|
[74]
|
Xiao, J., Wang, F., Wong, N.K., et al. (2019) Global Liver Disease Burdens and Research Trends: Analysis from a Chinese Perspective. Journal of Hepatology, 71, 212-221. https://doi.org/10.1016/j.jhep.2019.03.004
|
[75]
|
Loomba, R. and Adams, L.A. (2019) The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH. Hepatology, 70, 1885-1888. https://doi.org/10.1002/hep.30946
|
[76]
|
Lee, B.P., Vittinghoff, E., Dodge, J.L., et al. (2019) National Trends and Long-Term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States. JAMA Internal Medicine, 179, 340-348. https://doi.org/10.1001/jamainternmed.2018.6536
|
[77]
|
Pohl, K., Moodley, P. and Dhanda, A.D. (2021) Alcohol’s Impact on the Gut and Liver. Nutrients, 13, Article No. 3170. https://doi.org/10.3390/nu13093170
|
[78]
|
Yan, A.W., Fouts, D.E., Brandl, J., et al. (2011) Enteric Dysbiosis Associated with a Mouse Model of Alcoholic Liver Disease. Hepatology, 53, 96-105. https://doi.org/10.1002/hep.24018
|
[79]
|
Queipo-Ortuno, M.I., Boto-Ordónez, M., Murri, M., et al. (2012) Influence of Red Wine Polyphenols and Ethanol on the Gut Microbiota Ecology and Biochemical Biomarkers. The American Journal of Clinical Nutrition, 95, 1323-1334. https://doi.org/10.3945/ajcn.111.027847
|
[80]
|
Grander, C., Adolph, T.E., Wieser, V., et al. (2018) Recovery of Ethanol-Induced Akkermansia muciniphila Depletion Ameliorates Alcoholic Liver Disease. Gut, 67, 891-901. https://doi.org/10.1136/gutjnl-2016-313432
|
[81]
|
MCC, Lacerda, N.L., Ferreira, C.M., et al. (2014) Comparing the Effects of Acute Alcohol Consumption in Germ-Free and Conventional Mice: The Role of the Gut Microbiota. BMC Microbiology, 14, Article No. 240. https://doi.org/10.1186/s12866-014-0240-4
|
[82]
|
Zhong, X., Cui, P., Jiang, J., et al. (2021) Streptococcus, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 649060. https://doi.org/10.3389/fcimb.2021.649060
|
[83]
|
WHO-International Society of Hypertension (1999) Guidelines for the Management of Hypertension. Journal of Hypertension, 17, 151-183. https://doi.org/10.1097/00004872-199917020-00001
|
[84]
|
Wang, P.X., Deng, X.R., Zhang, C.H., et al. (2020) Gut Microbiota and Metabolic Syndrome. Chinese Medical Journal, 133, 808-816. https://doi.org/10.1097/CM9.0000000000000696
|
[85]
|
Escobar-Morreale, H.F. (2018) Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment. Nature Reviews Endocrinology, 14, 270-284. https://doi.org/10.1038/nrendo.2018.24
|
[86]
|
Garg, D. and Tal, R. (2016) The Role of AMH in the Pathophysiology of Polycystic Ovarian Syndrome. Reproductive BioMedicine Online, 33, 15-28. https://doi.org/10.1016/j.rbmo.2016.04.007
|
[87]
|
Parker, J. (2020) Understanding the Pathogenesis of Polycystic Ovary Syndrome: A Transgenerational Evolutionary Adaptation to Lifestyle and the Environment. ACNEM, 39, 18-26. https://doi.org/10.20944/preprints202112.0088.v1
|
[88]
|
Sherman, S.B., Sarsour, N., Salehi, M., et al. (2018) Prenatal Androgen Exposure Causes Hypertension and Gut Microbiota Dysbiosis. Gut Microbes, 9, 400-421. https://doi.org/10.1080/19490976.2018.1441664
|
[89]
|
Zhang, J., Sun, Z., Jiang, S., et al. (2019) Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis. mSystems, 4, e00017-19. https://doi.org/10.1128/mSystems.00017-19
|
[90]
|
Petrukhin, K., Lutsenko, S., Chernov, I., et al. (1994) Characterization of the Wilson Disease Gene Encoding a P-Type Copper Transporting ATPase: Genomic Organization, Alternative Splicing, and Structure/Function Predictions. Human Molecular Genetics, 3, 1647-1656. https://doi.org/10.1093/hmg/3.9.1647
|
[91]
|
Medici, V. and Weiss, K.H. (2017) Genetic and Environmental Modifiers of Wilson Disease. Handbook of Clinical Neurology, 142, 35-41. https://doi.org/10.1016/B978-0-444-63625-6.00004-5
|
[92]
|
Cai, X., Deng, L., Ma, X., et al. (2020) Altered Diversity and Composition of Gut Microbiota in Wilson’s Disease. Scientific Reports, 10, Article No. 21825. https://doi.org/10.1038/s41598-020-78988-7
|
[93]
|
Aleidi, S.M., Alnehmi, E.A., Alshaker, M., et al. (2021) A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients. Metabolites, 11, Article No. 628. https://doi.org/10.3390/metabo11090628
|
[94]
|
Seely, K.D., Kotelko, C.A., Douglas, H., et al. (2021) The Human Gut Microbiota: A Key Mediator of Osteoporosis and Osteogenesis. International Journal of Molecular Sciences, 22, Article No. 9452. https://doi.org/10.3390/ijms22179452
|
[95]
|
Wei, M., Li, C., Dai, Y., et al. (2021) High-Throughput Absolute Quantification Sequencing Revealed Osteoporosis-Related Gut Microbiota Alterations in Han Chinese Elderly. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 630372. https://doi.org/10.3389/fcimb.2021.630372
|
[96]
|
Das, M., Cronin, O., Keohane, D.M., et al. (2019) Gut Microbiota Alterations Associated with Reduced Bone Mineral Density in Older Adults. Rheumatology (Oxford), 58, 2295-2304. https://doi.org/10.1093/rheumatology/kez302
|
[97]
|
Xu, Z., Xie, Z., Sun, J., et al. (2020) Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis. Frontiers in Cellular and Infection Microbiology, 10, Article No. 160. https://doi.org/10.3389/fcimb.2020.00016
|
[98]
|
Takimoto, T., Hatanaka, M., Hoshino, T., et al. (2018) Effect of Bacillus subtilis C-3102 on Bone Mineral Density in Healthy Postmenopausal Japanese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Bioscience of Microbiota, Food and Health, 37, 87-96. https://doi.org/10.12938/bmfh.18-006
|
[99]
|
Per-Anders, J., Curiac, D., Ahren, I.L., et al. (2019) Probiotic Treatment Using a Mix of Three Lactobacillus Strains for Lumbar Spine Bone Loss in Postmenopausal Women: A Randomised, Double-Blind, Placebo Controlled, Multicentre Trial. The Lancet Rheumatology, 1, E154-E162. https://doi.org/10.1016/S2665-9913(19)30068-2
|
[100]
|
Nath, A., Molnár, M.A., Csighy, A., et al. (2018) Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels. Medicina, 54, Article No. 98. https://doi.org/10.3390/medicina54060098
|
[101]
|
Laitinen, K. and Gueimonde, M. (2019) Microbiota, Food, and Health. International Journal of Molecular Sciences, 20, Article No. 6329. https://doi.org/10.3390/ijms20246329
|
[102]
|
Bezirtzoglou, E. and Stavropoulou, E. (2011) Immunology and Probiotic Impact of the Newborn and Young Children Intestinal Microflora. Anaerobe, 17, 369-374. https://doi.org/10.1016/j.anaerobe.2011.03.010
|
[103]
|
Garcia-Mantrana, I., Selma-Royo, M., Alcantara, C., et al. (2018) Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. Frontiers in Microbiology, 9, Article No. 890. https://doi.org/10.3389/fmicb.2018.00890
|
[104]
|
Dowis, K. and Banga, S. (2021) The Potential Health Benefits of the Ketogenic Diet: A Narrative Review. Nutrients, 13, Article No. 1654. https://doi.org/10.3390/nu13051654
|
[105]
|
Ahmed, S.R., Bellamkonda, S., Zilbermint, M., et al. (2020) Effects of the Low Carbohydrate, High Fat Diet on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: Experience from a Community-Based Cohort. BMJ Open Diabetes Research & Care, 8, e000980. https://doi.org/10.1136/bmjdrc-2019-000980
|
[106]
|
Dashti, H.M., Mathew, T.C., Khadada, M., et al. (2007) Beneficial Effects of Ketogenic Diet in Obese Diabetic Subjects. Molecular and Cellular Biochemistry, 302, 249-256. https://doi.org/10.1007/s11010-007-9448-z
|
[107]
|
Shih, C.W., Hauser, M., Aronica, L., et al. (2020) Changes in Blood Lipid Concentrations Associated with Changes in Intake of Dietary Saturated Fat in the Context of a Healthy Low-Carbohydrate Weight-Loss Diet: A Secondary Analysis of the Diet Intervention Examining the Factors Interacting with Treatment Success (DIETFITS) Trial. The American Journal of Clinical Nutrition, 109, 433-441. https://doi.org/10.1093/ajcn/nqy305
|
[108]
|
Parada Venegas, D., De la Fuente, M.K., Landskron, G., et al. (2019) Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Frontiers in Immunology, 10, Article No. 277. https://doi.org/10.3389/fimmu.2019.01486
|
[109]
|
Cronin, P., Joyce, S.A., O’Toole, P.W., et al. (2021) Dietary Fibre Modulates the Gut Microbiota. Nutrients, 13, Article No. 1655. https://doi.org/10.3390/nu13051655
|
[110]
|
da Silva, T.F., Casarotti, S.N., de Oliveira, G.L.V., et al. (2021) The Impact of Probiotics, Prebiotics, and Synbiotics on the Biochemical, Clinical, and Immunological Markers, as Well as on the Gut Microbiota of Obese Hosts. Critical Reviews in Food Science and Nutrition, 61, 337-355. https://doi.org/10.1080/10408398.2020.1733483
|
[111]
|
Stavropoulou, E. and Bezirtzoglou, E. (2020) Probiotics in Medicine: A Long Debate. Frontiers in Immunology, 11, Article No. 2192. https://doi.org/10.3389/fimmu.2020.02192
|
[112]
|
Dimidi, E., Christodoulides, S., Scott, S.M., et al. (2017) Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Advances in Nutrition, 8, 484-494. https://doi.org/10.3945/an.116.014407
|
[113]
|
Collins, F.L., Rios-Arce, N.D., Schepper, J.D., et al. (2017) The Potential of Probiotics as a Therapy for Osteoporosis. Microbiology Spectrum, 5, 1-16. https://doi.org/10.1128/microbiolspec.BAD-0015-2016
|
[114]
|
Górska, A., Przystupski, D., Niemczura, M.J., et al. (2019) Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy. Current Microbiology, 76, 939-949. https://doi.org/10.1007/s00284-019-01679-8
|
[115]
|
Hart, S.P. and Marshall, D.J. (2009) Spatial Arrangement Affects Population Dynamics and Competition Independent of Community Composition. Ecology, 90, 1485-1491. https://doi.org/10.1890/08-1813.1
|
[116]
|
LeBlanc, J.G., Chain, F., Martín, R., et al. (2017) Beneficial Effects on Host Energy Metabolism of Short-Chain Fatty Acids and Vitamins Produced by Commensal and Probiotic Bacteria. Microbial Cell Factories, 16, Article No. 79. https://doi.org/10.1186/s12934-017-0691-z
|
[117]
|
Song, E.J., Han, K., Lim, T.J., et al. (2020) Effect of Probiotics on Obesity-Related Markers per Enterotype: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. EPMA Journal, 11, 31-51. https://doi.org/10.1007/s13167-020-00198-y
|
[118]
|
Sato, J., Kanazawa, A., Azuma, K., et al. (2017) Probiotic Reduces Bacterial Translocation in Type 2 Diabetes Mellitus: A Randomised Controlled Study. Scientific Reports, 7, Article No. 12115. https://doi.org/10.1038/s41598-017-12535-9
|
[119]
|
Zawistowska-Rojek, A. and Tyski, S. (2018) Are Probiotic Really Safe for Humans? Polish Journal of Microbiology, 67, 251-258. https://doi.org/10.21307/pjm-2018-044
|
[120]
|
Vallianou, N., Stratigou, T., Christodoulatos, G.S., et al. (2020) Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Current Obesity Reports, 9, 179-192. https://doi.org/10.1007/s13679-020-00379-w
|
[121]
|
Hume, M.P., Nicolucci, A.C. and Reimer, R.A. (2017) Prebiotic Supplementation Improves Appetite Control in Children with Overweight and Obesity: A Randomized Controlled Trial. The American Journal of Clinical Nutrition, 105, 790-799. https://doi.org/10.3945/ajcn.116.140947
|
[122]
|
Dehghan, P., Farhangi, M.A., Tavakoli, F., et al. (2016) Impact of Prebiotic Supplementation on T-Cell Subsets and Their Related Cytokines, Anthropometric Features and Blood Pressure in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Trial. Complementary Therapies in Medicine, 24, 96-102. https://doi.org/10.1016/j.ctim.2015.12.010
|
[123]
|
Javadi, L., Ghavami, M., Khoshbaten, M., et al. (2017) The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Iranian Red Crescent Medical Journal, 19, e46017. https://doi.org/10.5812/ircmj.46017
|
[124]
|
Raji Lahiji, M., Zarrati, M., Najafifi, S., et al. (2021) Effects of Synbiotic Supplementation on Serum Adiponectin and Inflammation Status of Overweight and Obese Breast Cancer Survivors: A Randomized, Triple-Blind, Placebo-Controlled Trial. Supportive Care in Cancer, 29, 4147-4157. https://doi.org/10.1007/s00520-020-05926-8
|
[125]
|
Horvath, A., Leber, B., Feldbacher, N., et al. (2020) Effects of a Multispecies Synbiotic on Glucose Metabolism, Lipid Marker, Gut Microbiome Composition, Gut Permeability, and Quality of Life in Diabesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. European Journal of Nutrition, 59, 2969-2983. https://doi.org/10.1007/s00394-019-02135-w
|
[126]
|
Cakir, M., Aksel Isbilen, A., Eyupoglu, I., et al. (2017) Effects of Long-Term Synbiotic Supplementation in Addition to Lifestyle Changes in Children with Obesity-Related Non-Alcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology, 28, 377-383. https://doi.org/10.5152/tjg.2017.17084
|
[127]
|
Salminen, S., Collado, M.C., Endo, A., et al. (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics. Nature Reviews Gastroenterology & Hepatology, 18, 649-667. https://doi.org/10.1038/s41575-021-00440-6
|
[128]
|
Lee, J., Park, S., Oh, N., et al. (2021) Oral intake of Lactobacillus plantarum L-14 Extract Alleviates TLR2- and AMPK-Mediated Obesity-Associated Disorders in High-Fat-Diet-Induced Obese C57BL/6J Mice. Cell Proliferation, 54, e13039. https://doi.org/10.1111/cpr.13039
|
[129]
|
Cheng, D., Xu, J.H., Li, J.Y., et al. (2018) Butyrate Ameliorated-NLRC3 Protects the Intestinal Barrier in a GPR43-Dependent Manner. Experimental Cell Research, 368, 101-110. https://doi.org/10.1016/j.yexcr.2018.04.018
|
[130]
|
Ye, J., Lv, L., Wu, W., et al. (2018) Butyrate Protects Mice against Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels. Frontiers in Microbiology, 9, Article No. 1967. https://doi.org/10.3389/fmicb.2018.01967
|
[131]
|
Maykish, A. and Sikalidis, A.K. (2020) Utilization of Hydroxyl-Methyl Butyrate, Leucine, Glutamine and Arginine Supplementation in Nutritional Management of Sarcopenia-Implications and Clinical Considerations for Type 2 Diabetes Mellitus Risk Modulation. Journal of Personalized Medicine, 10, Article No. 19. https://doi.org/10.3390/jpm10010019
|
[132]
|
Raqib, R., Sarker, P., Mily, A., et al. (2012) Efficacy of Sodium Butyrate Adjunct Therapy in Shigellosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. BMC Infectious Diseases, 12, Article No. 111. https://doi.org/10.1186/1471-2334-12-111
|
[133]
|
Schmidt, E.K.A., Raposo, P.J.F., Torres-Espin, A., et al. (2021) Beyond the Lesion Site: Minocycline Augments Inflammation and Anxiety-Like Behavior Following SCI in Rats through Action on the Gut Microbiota. Journal of Neuroinflammation, 18, Article No. 144. https://doi.org/10.1186/s12974-021-02123-0
|
[134]
|
Garrido-Mesa, J., Rodríguez-Nogales, A., Algieri, F., et al. (2018) Immunomodulatory Tetracyclines Shape the Intestinal Inflammatory Response Inducing Mucosal Healing and Resolution. British Journal of Pharmacology, 175, 4353-4370. https://doi.org/10.1111/bph.14494
|
[135]
|
Hu, P., Thinschmidt, J.S., Yan, Y., et al. (2013) CNS Inflammation and Bone Marrow Neuropathy in Type 1 Diabetes. The American Journal of Pathology, 183, 1608-1620. https://doi.org/10.1016/j.ajpath.2013.07.009
|
[136]
|
Yellowlees Douglas, J., Bhatwadekar, A.D., Li Calzi, S., et al. (2012) Bone Marrow-CNS Connections: Implications in the Pathogenesis of Diabetic Retinopathy. Progress in Retinal and Eye Research, 31, 481-494. https://doi.org/10.1016/j.preteyeres.2012.04.005
|
[137]
|
Pepine, C.J., Thiel, A., Kim, S., et al. (2021) Potential of Minocycline for Treatment of Resistant Hypertension. American Journal of Cardiology, 156, 147-149. https://doi.org/10.1016/j.amjcard.2021.07.004
|
[138]
|
Kim, K.O. and Gluck, M. (2019) Fecal Microbiota Transplantation: An Update on Clinical Practice. Clinical Endoscopy, 52, 137-143. https://doi.org/10.5946/ce.2019.009
|
[139]
|
Surawicz, C.M., Brandt, L.J., Binion, D.G., et al. (2013) Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. American Journal of Gastroenterology, 108, 478-498. https://doi.org/10.1038/ajg.2013.4
|
[140]
|
Yu, E.W., Gao, L., Stastka, P., et al. (2020) Fecal Microbiota Transplantation for the Improvement of Metabolism in Obesity: The FMT-TRIM Double-Blind Placebo-Controlled Pilot Trial. PLOS Medicine, 17, e1003051. https://doi.org/10.1371/journal.pmed.1003051
|
[141]
|
Zhong, H.J., Zeng, H.L., Cai, Y.L., et al. (2021) Washed Microbiota Transplantation Lowers Blood Pressure in Patients with Hypertension. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 679624. https://doi.org/10.3389/fcimb.2021.679624
|
[142]
|
Ng, S.C., Xu, Z., Mak, J.W.Y., et al. (2022) Microbiota Engraftment after Faecal Microbiota Transplantation in Obese Subjects with Type 2 Diabetes: A 24-Week, Double-Blind, Randomised Controlled Trial. Gut, 71, 716-723. https://doi.org/10.1136/gutjnl-2020-323617
|
[143]
|
Singh, V., Roth, S., Llovera, G., et al. (2016) Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. Journal of Neuroscience, 36, 7428-7440. https://doi.org/10.1523/JNEUROSCI.1114-16.2016
|
[144]
|
Spychala, M.S., Venna, V.R., Jandzinski, M., et al. (2018) Age-Related Changes in the Gut Microbiota Influence Systemic Inflammation and Stroke Outcome. Annals of Neurology, 84, 23-36. https://doi.org/10.1002/ana.25250
|
[145]
|
Zheng, W., Zhao, S., Yin, Y., et al. (2022) High-Throughput, Single-Microbe Genomics with Strain Resolution, Applied to a Human Gut Microbiome. Science, 376, eabm1483. https://doi.org/10.1126/science.abm1483
|
[146]
|
Kumar, P., Sinha, R. and Shukla, P. (2022) Artificial Intelligence and Synthetic Biology Approaches for Human Gut Microbiome. Critical Reviews in Food Science and Nutrition, 62, 2103-2121. https://doi.org/10.1080/10408398.2020.1850415
|
[147]
|
Kendall, M.M. and Sperandio, V. (2021) Gut Microbes Regroup to Aid Defence after Infection. Nature, 592, 29-31. https://doi.org/10.1038/d41586-021-00642-7
|